N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.

导出 LinkOut

翻译打印收藏纠错

作者： Min,Mo ^[1] ; Yao,Zeng ^[2] ; Yiqun,Zeng ^[2] ; Shuting,Li ^[2] ; Xiaoyang,He ^[2] ; Xiaowen,Chen ^[2] ; Qimei,Luo ^[3] ; Mi,Liu ^[3] ; Congwei,Luo ^[2] ; Xianrui,Dou ^[4] ; Fenfen,Peng ^[5] ; Haibo,Long ^[6]

作者单位： Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China; Department of Nephrology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, 528308, China. ^[1] Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. ^[2] Department of Nephrology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, 528308, China. ^[3] Department of Nephrology, Shunde Hospital, Southern Medical University (The First People's Hospital of Shunde), Foshan, 528308, China. Electronic address: betty9911@163.com. ^[4] Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. Electronic address: doctorpff@163.com. ^[5] Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. Electronic address: longhb1966@163.com. ^[6]

关键词 Epithelial-mesenchymal transition Fibrosis Ovatodiolide Peritoneal dialysis TGF-β/Smad